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1) What is food additive intolerance and can you tell us
what the most common symptoms are?
Food additive intolerance is a non-IgE mediated food
hypersensitivity. The hypersensitivity is induced by the
food additives via a direct mast cell activation. Although
the exact pathophysiology is unknown, various clinical
signs are characteristic of food additive intolerance. These
include cutaneous symtoms like redness of the skin, urti-
caria and angioedema as well as other organ related symp-
toms, such as dyspnea, hypotension or dizziness.
2) What are the differences between intolerance and
allergy?
Both, IgE-mediated allergy, but also food additive intoler-
ance are mast cell dependent reactions. The release of
mast cell mediators like histamine, leukotrienes and others
leads to the onset of the above mentioned clinical symp-
toms, which cannot be distinguished concerning the
underlying mechanisms. In the case of an allergic reaction,
crosslinking of membrane bound IgE via an allergen is
inducing mast cell degranulation. In food additive intoler-
ance a direct action of the additive on the mast cells is
proposed, however the exact mechanisms are not known.
3) What are the most common food additives that cause
intolerance?
The most common food additives to which patients are
intolerant are sulfite, sodium benzoate and food colorings.
In addition, histamine is often accused of inducing intoler-
ance reactions, however its exact role as an intolerance
reaction as such requires more clarification.
4) What is the prevalence of food intolerance?
It is estimated that 0.1 - 1.5% of the population may suffer
from food additive tolerance. So far the data suggest that
intolerance reactions occur more frequently in older
patients rather than in young children Further, it is known
that drug intolerance towards acetylsalicylic acid (ASA)
occurs more frequently in asthmatic patients. However,
whether this is also true in respect to the prevalence of
food intolerance in asthmatics remains to be determined.
5) Is there an age dependent increase in allergy risk and
what are the reasons for this?
T h er i s ko fd e v e l o p i n ga na l l e r g yt om yk n o w l e d g ed o e s
not solely depend on age but rather depends on the aller-
g e na n dt h es p e c i f i ce x p o s u r es ituation of an individual.
The lifetime risk for a food allergy probably does decrease
rather than increase over time. However, in the case of
food additive intolerance, this decrease of the risk over
time might not be true. A possible explanation for this
might be a change of the gastrointestinal barrier function.
In addition the presence of additional cofactors, which can
trigger such reactions (intake of drugs like ACE-inhibitors,
physical activity, in-take of alcohol), makes the onset of
food additive intolerance in later life more likely.
6) Are there any co-morbidities that increase the risk of
being intolerant to food additives?
As mentioned above, probably patients with moderate to
severe asthma are at a higher risk of being of intolerant to
food additives. In addition, it is well known that patients
who suffer from mastocytosis, a genetic disease where
mast cells occur in increased numbers in the skin and
other organs have an increased risk to develop systemic-
reactions to food additives
7) What are the current diagnostic and management
strategies for food additive intolerance?
To date, the optimal management strategies for food addi-
tive intolerance include the avoidance of an increased
intake of food additives in general, in particular in large
amounts. For example, a meal with ripened cheese, wine
and a colored dessert should be avoided. If a patient has
skin and gastrointestinal symptoms, a prophylactic intake
of antihistamines might be useful. Diagnostic procedures
involve an elimination diet (3 - 4 weeks) followed by dou-
ble blind-placebo-controlled-food challenge (DBPCFC)
tests. Only if the double blind-placebo-controlled-food
challenge is positive the diagnosis can be proven and
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patients suffering from chronic urticaria has indicated a
change in diet can facilitate gastrointestinal barrier recov-
ery, which enables the patient to include certain food
items step by step again over time again.
8) Are there any difficulties in the diagnosis of food
additive intolerance?
The major difficulties in the diagnosis of food additive
intolerance are that the history of symptoms made by the
patients might not be clear. In such cases, a symptom
diary might be helpful. It is important to note that in vivo
tests, such as the skin prick-test, and in vitro tests such as
determination of specific IgE cannot be used to make the
diagnosis. Moreover, other methods such as the cellular
activation test (CAST) measuring histamine release and/or
the leukotriene pathway production can not be recom-
mended to confirm the diagnosis. Therefore, research in
this area is urgently required. This would help to improve
the diagnostic methods of food additive intolerance, iden-
tify patients at risk and would support the development of
new therapeutic strategies. The lack of knowledge in this
field is e.g. related to the fact that food additive intolerance
cannot be studied well in vitro as mast cell reactivity is dif-
ferent if studied in vitro versus in vivo.
9) What does the future hold for the diagnosis and
management of food additive allergies?
I am sure that in the future we will be able to come up
with novel diagnostic approaches. These might be based
on cellular test systems and/or a metabolomic analysis
from patients’ serum. In particular, mediators and their
receptors from the leukotriene pathway should be consid-
ered in more detail as data from previous studies suggest
that genetic polymorphisms of leukotriene receptors may
be influential, as well as deviations within the leukotriene
profile might be relevant. In terms of medical strategies,
the exact role of the gastrointestinal barrier will need
more clarification. If methods can be developed to increase
the barrier function of the gut these might also offer novel
approaches for food intolerant patients because less
absorption or enhanced local degradation of the food addi-
tive in the gut would decrease the systemic burden.
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